'Gene silencing' may improve treatment of a deadly complication of liver disease

A technique that “silences,” or turns off, genes shows promise as a potential new treatment for liver fibrosis — the disease that leads to cirrhosis — scientists in Tennessee are reporting. Their study is scheduled for the June 1 issue of ACS’ Molecular Pharmaceutics. Cirrhosis is the 12th leading cause of death in the United States.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news162667470.html">'Gene silencing' may improve treatment of a deadly complication of liver disease</a></p> <p>A technique that “silences,” or turns off, genes shows promise as a potential new treatment for liver fibrosis — the disease that leads to cirrhosis — scientists in Tennessee are reporting. Their study is scheduled for the June 1 issue of ACS’ <i>Molecular Pharmaceutics</i>. Cirrhosis is the 12th leading cause of death in the United States.</p>